Navigation Links
Cancer Experts Detail Treatments using TrueBeam System to Reduce Number of Treatment Sessions and Take Better Account of Motion
Date:5/11/2012

d in a standard 15 minute treatment slot rather than in conventional radiosurgery sessions that are typically two to five times longer. We are pleased with the clinical experience and patient response."

Prof. Carlo Greco from the University of Pisa in Italy described his clinic's experience with real-time tracking of prostate cancer using the Varian Calypso® system, which involves the use of implantable beacons to monitor motion by tracking movement in real time with sub-millimeter precision.

"Calypso enabled us to detect and measure motion during treatments so that we could plan to deliver doses within tighter margins around the disease site in order to reduce toxicity and complications in surrounding healthy tissue," said Prof. Greco. "Prostate motion occurs even during very short RapidArc treatments and detecting and correcting for this is of paramount importance when adopting hypo-fractionated schedules that involve delivering higher doses within each treatment session."

The Varian's Emerging Technologies Symposium was chaired and moderated by Professor Ben Slotman, head of radiation oncology at VU Medical Center in Amsterdam, The Netherlands.

Also at ESTRO 2012, Varian hosted a lunch symposium assessing different ways of delivering post-lumpectomy partial breast irradiation, with the relative benefits of external beam radiotherapy, intra-operative irradiation and brachytherapy examined. This session was moderated by Prof. Dr. Peter Niehoff of Koln Merheim Hospital in Germany and the debaters were Douglas Arthur, M.D. of Virginia Commonwealth University School of Medicine in the USA and Frank Sullivan, M.D. of Galway University Hospital in Ireland.  

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and oth
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Guangzhous Sun Yat-sen University Cancer Center Debuts MOSAIQ in the Chinese Platform
3. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
4. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
5. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
6. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
7. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
8. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
9. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 Perrigo Company plc, a public limited company ... (the " Company "), today announced that it is offering ... new 1.30% Senior Notes due 2016 (the " 2016 Exchange ... 2018 (the " 2018 Exchange Notes "), $800,000,000 of its ... Notes ") and $400,00,000 of its new 5.30% Senior Notes ...
(Date:9/2/2014)... AUSTIN, Texas , Sept. 2, 2014 /PRNewswire/ ... Phase III study being conducted in the US ... a True Human™ monoclonal antibody therapy, is being ... is further complicated with cachexia. The primary endpoint ... in Xilonix treated patients to a control population ...
(Date:9/2/2014)... NEW YORK , Sept. 2, 2014 /PRNewswire/ ... report is available in its catalogue: ... 2014 http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html ... H2, 2014 Summary GlobalData,s clinical ... Review, H2, 2014" provides data on the Acute ...
Breaking Medicine Technology:Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 2Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 3Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 4XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8
... Work Status and,Productivity, WASHINGTON, May 23, 2007 /PRNewswire-FirstCall/ ... (DDW), from,long-term extensions of the ACT trials (Active ... moderately to severely active,ulcerative colitis (UC) who had ... the trials maintained,improvement in their clinical symptoms for ...
... WIRE)--May 23, 2007 - Synta,Pharmaceuticals Corp., (NASDAQ: ... and commercializing small,molecule drugs to treat severe ... data from the Phase 2b clinical,trial in ... drug,candidate, STA-4783, will be presented at the ...
Cached Medicine Technology:Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 2Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 3Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 4Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 5Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 6Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 7Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 8Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 9Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3
(Date:9/3/2014)... Pwnie Express today announced the release ... Plug, the R3, an inconspicuous pentesting device whose drop ... remote locations at a fraction of the cost of ... the only company to assess wired and wireless network ... a next-generation penetration testing device in a portable, shippable, ...
(Date:9/3/2014)... 03, 2014 Morris Psychological ... free screenings for depression on October 9, 2014 ... Court). More than 1,000 organizations nationwide will be ... colleges and military installations. After completing a screening, ... and agencies that can offer further evaluation and ...
(Date:9/2/2014)... 03, 2014 Autumn is well ... to celebrate the new season with worldwide people. ... and announced that Hostgator ( http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts ), Arvixe, ... of 2014. , Since 2002 HostGator has ... and the company’s reputation for reliability remains with ...
(Date:9/2/2014)... Fla. (PRWEB) September 02, 2014 ... join together in Tampa Bay from September 4-6 ... annual Scientific Symposium and FARA Energy Ball Gala. ... USF Ataxia Research Center in their pursuit of ... affected by the progressive neuromuscular disease Friedreich’s ataxia ...
(Date:9/2/2014)... 03, 2014 UWDress.com, an experienced supplier ... added a lot of fashionable bridesmaid dresses ... company has launched a special offer to celebrate the ... from 20 to 60 percent off. , The ... announce our new fashionable bridesmaid dresses for consumers from ...
Breaking Medicine News(10 mins):Health News:Pwnie Express Releases Next Generation Penetration Testing Device: The Pwn Plug R3 2Health News:Pwnie Express Releases Next Generation Penetration Testing Device: The Pwn Plug R3 3Health News:Pwnie Express Releases Next Generation Penetration Testing Device: The Pwn Plug R3 4Health News:Screenings for Depression by Morris Psychological Group, October 9, 2014 from 4:30 to 8:30pm, Rockaway Townsquare Mall (Macy’s Court) 2Health News:Top10BestSEOHosting.com Celebrates The Coming Of Autumn And Release Reseller Hosting Suppliers Of 2014 2Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 2Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 3Health News:Elegant Bridesmaid Dresses For 2014, Latest Designs From UWDress.com 2
... DENVER, July 28 ThinIdentity Corporation, a ... announced that Alegent Health is moving forward with plans ... The first installation is located at its Mercy Hospital ... has over 1,000 caregivers using the ThinIdentity solution to ...
... , WILMINGTON, Delaware, July 28 ... - 2014), published by,MarketsandMarkets ( http://www.marketsandmarkets.com ), the total drug-device,combination ... out of,which the U.S. market will account for nearly 30.9% ... a CAGR of 11.8% from 2009 to 2014. , ...
... ... CompactRIO embedded real-time platform at the 15th annual NIWeek, opening Aug. 4 at the ... and exhibition hosted by National Instruments. , ... Irvine, CA (PRWEB) July 27, 2009 -- MoviMED ( www.movimed.com ...
... ... find medical assistant training at All Allied Health Schools. , ... Seattle, Wash. (PRWEB) July 28, 2009 -- With current unemployment ... In 2006, the Bureau of Labor Statistics predicted 35 percent growth in medical assistant ...
... ... centers and healthcare facilities acquire financing for new and professionally refurbished medical equipment. , ... (Vocus) July 28, 2009 -- With ... to purchase medical equipment . DRE, Inc. — named a Company of the Year ...
... , ... Cleanroom wipers manufactured by Teknipure offer innovative ... to finish in one facility enabling maximum quality control and are ... Basis Weight, Sorbency, Liquid Particle Count, Non-Volatile Residue levels, Ionic Extractable ...
Cached Medicine News:Health News:Alegent Health Turns to ThinIdentity(TM) to Improve Caregiver Productivity 2Health News:Alegent Health Turns to ThinIdentity(TM) to Improve Caregiver Productivity 3Health News:Drug-Device Combination Market Worth US$18.54 Billion by 2014 2Health News:Drug-Device Combination Market Worth US$18.54 Billion by 2014 3Health News:MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Advantage 2Health News:MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Advantage 3Health News:Students Connect with Stable Careers Through Updated Medical Assistant Career Resources on All Allied Health Schools 2Health News:Students Connect with Stable Careers Through Updated Medical Assistant Career Resources on All Allied Health Schools 3Health News:Financing Available for Healthcare Equipment from DRE Medical Equipment 2Health News:Financing Available for Healthcare Equipment from DRE Medical Equipment 3Health News:Teknipure Cleanroom Wipers Offer Innovative Solutions for Contamination Control Engineers 2
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Flat handle....
McPherson handle. 45 degree angled shafts. Manufactured in titanium....
This cross action forcep has delicate tips for grasping the capsule. The forcep has an iris stop to prevent inadvertent grasping of the iris....
Similar in construction to the E2002 Utrata Capsulorhexis Forceps with jaw set to open only 3 mm. Flat handle with dull finish....
Medicine Products: